Home
Search

Speakers & Presenters

Register

2020 Speakers & Presenters

Check back regularly for new speakers and presenters. 

Featured Speakers
Peter Lee
Peter Lee
CORPORATE VICE PRESIDENT, MICROSOFT HEALTHCARE, MICROSOFT
Dr. Peter Lee is Corporate Vice President, Microsoft Healthcare. He leads an organization that works on technologies for better and more efficient…
Peter Marks
Peter Marks, MD, PhD
DIRECTOR, CENTERS FOR BIOLOGICS EVALUATION & RESEARCH, US FOOD & DRUG ADMINISTRATION
Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine…
Natalie Holles
Natalie Holles
PRESIDENT AND CHIEF EXECUTIVE OFFICER, AUDENTES, AN ASTELLAS COMPANY
Natalie Holles has served as President and Chief Executive Officer (CEO) of Audentes since January 2020. She joined the company as Senior Vice…
Peter Lee
Peter Marks
Natalie Holles
All Speakers
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Christopher Bahl, MS, PhD
HEAD OF PROTEIN DESIGN, INSTITUTE FOR PROTEIN INNOVATION
New Frontiers in Computational Protein Design
Institute for Protein Innovation
Boston, Massachusetts, United States
photo
Mitchell Finer, BS, PhD
CHIEF SCIENTIFIC OFFICER, ELEVATEBIO
CARs in the Fast Lane? Universal Allogeneic Therapy Moving Forward
Cambridge, Massachusetts, United States
photo
Adi Frish
SENIOR VP BUSINESS DEVELOPMENT AND LICENSING, REDHILL BIOPHARMA
RedHill Biopharma
Tel Aviv, Israel
photo
Chris Garabedian
CHAIRMAN & CEO, XONTOGENY
Derisking Early Research and Increasing Likelihood of Clinical Success
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
Boston, Massachusetts, United States
photo
Julie Gerberding
EXECUTIVE VICE PRESIDENT & CHIEF PATIENT OFFICER, MERCK & CO, INC.
The Next Frontier in HIV Innovation: the Transition to No Transmission
North Wales , Pennsylvania, United States
photo
Ricky Ghoshal
VICE PRESIDENT, BUSINESS DEVELOPMENT, GLYSANTIS INC.
Glysantis Inc.
Guelph, Ontario, Canada
photo
Moira Gunn, BS, MS, PhD
HOST, TECH NATION ON THE NPR CHANNEL ON SIRIUSXM, AND ASSOCIATE PROFESSOR, UNIVERSITY OF SAN FRANCISCO, NPR
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
San Francisco, California, United States
photo
Patricia Hurter
CEO, LYNDRA THERAPEUTICS
Lyndra Therapeutics
Watertown , Massachusetts, United States
photo
Daniel Jorgensen, MBA, MD, MPH
CHIEF MEDICAL OFFICER, OCUGEN, INC.
Ocugen, Inc.
Malvern, Pennsylvania, United States
photo
Nina Kjellson
MANAGING PARTNER, CANAAN PARTNERS
Perspectives on Translational Research
Persuasive Pitching – Do You Have the Talent to Engage Investors?
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
Menlo Park, California, United States
photo
Jeremy Abbate
VICE PRESIDENT & PUBLISHER , SCIENTIFIC AMERICAN
How Can the Liquid Biopsy Market Realize Its $30B Potential?
New York , New York, United States
photo
Sherin Abdel-Meguid
PRESIDENT, SHIFA BIOMEDICAL CORPORATION
Shifa Biomedical Corporation
Exton, Pennsylvania, United States
photo
Wade Ackerman, JD
PARTNER, COVINGTON & BURLING
Patient-centricity 2.0: Are we ready for decentralized trials?
Los Angeles, California,
photo
Julian Adams
CEO, GAMIDA CELL
Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer
Boston, Massachusetts, United States
photo
Sudhir Agarwal, D. Phil, FRSC
FOUNDER, IDERA PHARMACEUTICALS
'N of Few' - Clinical Trial Design for Small Cohorts
photo
Amirah Al Idrus
COPY EDITOR, FIERCEMARKETS
Diversity and inclusion's biotech explosion: ERG and non-profit perspectives
Washington, District Of Columbia  , United States
photo
Meg Alexander
HEAD, REPUTATION & RISK MANAGEMENT PRACTICE, SYNEOS HEALTH
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact without Congressional Authority?
New York, New York, United States
photo
Khatija Ali
CEO, BIOSAPIEN INC.
BioSapien Inc.
New York, New York, United States
photo
Jeff Allen
PRESIDENT AND CEO, FRIENDS OF CANCER RESEARCH
Patient-centricity 2.0: Are we ready for decentralized trials?
Washington, DC, District Of Columbia  , United States
photo
Fumito Aranami
MANAGER, OITA IAM
Oita IAM
Oita , Jordan
photo
Arsalan Arif
CEO AND FOUNDER, ENDPOINTS NEWS
Gene therapy: The long horizon and broad challenges
Lawrence, Kansas, United States
photo
Simon Arkell
PRESIDENT AND CO-FOUNDER, DEEP LENS
Deep Lens, Inc.
Columbus, Ohio, United States
photo
Iain Armstrong
PARTNER, HGF INTELLECTUAL PROPERTY SPECIALISTS
CAR-T cell therapy: filing trends, opportunities and challenges to patentability
photo
Sasha Bakhru
PRESIDENT & CHIEF EXECUTIVE OFFICER, PEROSPHERE TECHNOLOGIES
Addressing the neglect in cardiovascular Disease development
photo
Jenny Barnett
CHIEF SCIENTIFIC OFFICE, CAMBRIDGE COGNITION
Digital biomarkers - a new dawn in CNS R&D
Cambridge, United Kingdom
photo
Marcel Bassil
ASSOCIATE DIRECTOR BIOTECH , BENTA PHARMA INDUSTRIES
Benta Pharma Industries
Byblos, Lebanon
photo
Milena Batalla
CEO, PANARUM
Panarum
Buenos Aires City, Argentina
photo
Amber Batata, PhD
GLOBAL HEAD OF VALUE & ACCESS, RARE DISEASES & RARE BLOOD DISORDERS, SANOFI GENZYME
Financing transformative therapies: Specifying new and multi-party payment models
Cambridge, Massachusetts, United States
photo
Jake Bauer
CHIEF BUSINESS OFFICER, MYOKARDIA
Precision Medicine Outside Oncology: One Size Does Not Fit All
San Francisco, California, United States
photo
Susan Baxter, PhD
EXECUTIVE DIRECTOR, CALIFORNIA STATE UNIVERSITY PROGRAM FOR EDUCATION AND RESEARCH IN BIOTECHNOLOGY
Diversity and Inclusion in the Bio-innovation Ecosystem
San Diego, California, United States
photo
Joanne Beck
EVP, PHARMACEUTICAL DEVELOPMENT & OPERATIONS, CELGENE
Discover/Develop, but how will you Manufacturing your therapeutic?
Summit, New Jersey, United States
photo
Sergi Beltran
HEAD OF THE BIOINFORMATICS UNIT, SPANIGH NATIONAL CENTRE OF GENOMIC ANALYSIS
Can artificial intelligence break the rare disease deadlock?
Barcelona, Spain
photo
Jeff Berkowitz
STRATEGIC ADVISOR/ FORMER CMO, CEO REAL ENDPOINTS
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
Madisoin, New Jersey, United States
photo
Sylvain Berlemont
CEO, KEEN EYE
KEEN EYE
Paris, France
photo
Amy Bertha
SENIOR DIRECTOR, REGULATORY POLICY , BAYER
Does the U.S. FDA’s New Drugs Regulatory Program Modernization Impact your Drug Development Program?
photo
Lyla Bibi
MANAGING DIRECTOR , GOLDMAN SACHS
Capital Markets Crystal Ball: Strategies for Equity Financing
New York , New York, United States
photo
Barbara Bierer, MD
FACULTY DIRECTOR, MULTI-REGIONAL CLINICAL TRIALS CENTER OF BRIGHAM AND WOMEN'S HOSPITAL AND HARVARD
Incorporating the Patient Voice in Biotech – Innovations in Patient and Community Engagement that Advance Diverse Inclusion and Support Clear Research Communication
Cambridge, Massachusetts, United States
photo
Lara Bloom
PRESIDENT AND CEO, THE EHLERS-DANLOS SOCIETY
Can artificial intelligence break the rare disease deadlock?
London, United Kingdom
photo
Jeffrey Bockman, PhD
EVP, ONCOLOGY PRACTICE HEAD, CELLO HEALTH BIOCONSULTING (PREVIOUSLY DEFINED HEALTH)
Future of IO Checkpoint Combinations
photo
Sierra Bodor, BS
PUBLIC HEALTH PROGRAM MANAGER, HEPATITIS B FOUNDATION
Developing a new diagnostic for a rare disease to fuel clinical trials and build a market
Doylestown, Pennsylvania, United States
photo
Harm-Jan Borgeld
VICE PRESIDENT, HEAD OF ALLIANCE MANAGEMENT, MERCK HEALTHCARE KGAA
Striking the delicate balance of externalizing biopharma R&D to maximize innovation: Strategies to buy vs. build
Darmstadt, Germany
photo
Page Bouchard
SVP AND CHIEF SCIENTIFIC OFFICER, AVEXIS, AVEXIS, INC., A NOVARTIS COMPANY
AveXis, Inc., a Novartis Company
Bannockburn, Illinois, United States
photo
Matt Bradley, PhD
CHAIRMAN, PRESIDENT, FOUNDER, SAJE PHARMA, LLC
SAJE Pharma, LLC
Kalispell, Montana, United States
photo
Kerrie Brady, Bpharm, MBA, MSc
CO-FOUNDER AND FORMER CBO CENTREXION
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
United States
photo
Brian Branchford
ASSISTANT PROFESSOR, UNIVERSITY OF COLORADO
Addressing the neglect in cardiovascular Disease development
photo
Isaac Bright
CEO, RUBRYC THERAPEUTICS, INC.
RubrYc Therapeutics, Inc.
San Carlos, California, United States
photo
Remy Brim, PhD
VICE PRESIDENT; CO-LEAD, FDA & PUBLIC HEALTH WORKING GROUP, BGR GOVERNMENT AFFAIRS
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact without Congressional Authority?
Washington, District Of Columbia  , United States
photo
Jason Brown, PhD
CHIEF BUSINESS OFFICER, EVEREST MEDICINES
Licensing Clinical-Stage Assets to Greater China
San Diego, California, United States
photo
Ronan Brown
SENIOR VP & HEAD, INTEGRATED GLOBAL COMPLIANCE, IQVIA, IQVIA
IQVIA
San Diego, California, United States
photo
Nick Brown
NORTH AMERICAN BUSINESS DEVELOPMENT MANAGER, RETROGENIX LIMITED
Retrogenix Limited
Chinley, High Peak, United Kingdom
photo
Matt Bryant, PharmD
VP, GLOBAL MEDICAL AFFAIRS, EIGER BIOPHARMACEUTICALS
Developing a new diagnostic for a rare disease to fuel clinical trials and build a market
Palo Alto, California, United States
photo
John Cabeca
DIRECTOR, SILICON VALLEY USPTO, USPTO
WHY PATENTS STILL MATTER: Developing a Global Patent Portfolio of Real Value as Your Company Grows
San Jose, California, United States
photo
Euan Cameron
CEO/MANAGING DIRECTOR , COHESION MEDICAL LTD.
COHESION Medical Ltd.
Glasgow , United Kingdom
photo
Susan Cantrell, CAE, RPh
CHIEF EXECUTIVE OFFICER, ACADEMY OF MANAGED CARE PHARMACY
Persuading Payers to Pay for Digital Therapeutics: How do you get coverage when doctors prescribe software? Real-outcomes data and DTx-related physician coding will help.
Arlington, Virginia, United States
photo
Steve Carney
MANAGING EDITOR, DRUG DISCOVERY TODAY
Finding hidden treasure - how AI/ML can harness existing data to accelerate drug discovery
Digital biomarkers - a new dawn in CNS R&D
Richmond, United Kingdom
photo
John Carpten, PhD
PROFESSOR, CHAIR, AND DIRECTOR, UNIVERSITY OF SOUTHERN CALIFORNIA
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
Los Angeles, California, United States
photo
Alan Carr
SENIOR ANALYST, NEEDHAM & CO.
How to fix the broken antibiotics market: a rare/orphan diseases case study
New York, New York, United States
photo
Rich Carter
VICE PRESIDENT, CHIEF DIGITAL OFFICER, ELI LILLY AND COMPANY
The emerging role of digital biomarkers in cognitive impairment
Indianapolis, Indiana,
photo
Alan Cash
CEO, METVITAL, INC.
MetVital, Inc.
San Diego, California, United States
photo
John Chapman
PRESIDENT, STEM CELL PARTNERS LLC
Stem Cell Partners LLC
Sacramento, CA , California, United States
photo
Robert Charles, JD, LLM, MPH
CHIEF, MEDICAL RESEARCH LAW, US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
How to Leverage Military Non-Dilutive Funding for your Product Development Plan
Fort Detrick, Maryland, United States
photo
Anatoly Chernyshev
DIRECTOR, XR PHARMACEUTICALS LTD.
XR Pharmaceuticals Ltd
Cambridge, New Zealand
photo
Ho Cho, Ph.D.
VICE PRESIDENT OF BIOTHERAPEUTICS, CELGENE
Bispecific Antibodies Catching Fire
San Diego, California, United States
photo
Eunjong Choi
CEO, CUBEBIO
CUBEBIO
Seoul, Korea - South Korea
photo
Alan Choi
VICE PRESIDENT, ILDONG PHARMACEUTICAL CO
Ildong Pharmaceutical Co., Ltd
Hwaseong, Korea - South Korea
photo
Kang Yell Choi
CEO, CK BIOTECH INC
CK Biotech Inc
Seoul, Korea - South Korea
photo
Faz Chowdhury
CEO, NEMAURA PHARMA LIMITED
Nemaura Pharma Limited
Loughborough, United Kingdom
photo
Ryan Cirz
CHIEF SCIENTIFIC OFFICER, ACTING CHIEF EXECUTIVE OFFICER, REVAGENIX, INC.
How to fix the broken antibiotics market: a rare/orphan diseases case study
South San Francisco, California, United States
photo
Paul Cizdziel
GLOBAL MARKET DEVELOPMENT, YOKOGAWA ELECTRIC CORPORATION
Yokogawa Electric Corporation
Yokohama, Japan
photo
Ciara Clancy
CEO, BEATS MEDICAL
Beats Medical
Dublin, Ireland
photo
Andrew Clarke, PhD
HEAD OF BIOTECHNOLOGY, JAMES AND WELLS
Naturally-Derived Compositions - Tricks & Tips to Navigate Key Jurisdictions
Fortitude Valley, Australia
photo
Nigel Clarke
MANAGER, PATENT INFORMATION, PROMOTION & RESEARCH, EUROPEAN PATENT OFFICE
CAR-T cell therapy: filing trends, opportunities and challenges to patentability
photo
Chad Coberly, JD
EXECUTIVE VICE PRESIDENT, CLINICAL, REGULATORY & LEGAL AFFAIRS, TETRA THERAPEUTICS
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
Grand Rapids, Michigan, United States
photo
Jennifer Cochran, Ph.D.
SHRIRAM CHAIR OF THE DEPARTMENT OF BIOENGINEERING AT STANFORD UNIVERSITY, STANFORD UNIVERSITY
Bispecific Antibodies Catching Fire
Stanford, California, United States
photo
Ezra Cohen
MEDICAL ONCOLOGIST, ASSOCIATE DIRECTOR, TRANSLATIONAL SCIENCE, MOORES CANCER CENTER, UC SAN DIEGO HEALTH
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
La Jolla, California, United States
photo
Ellen Coleman
PRESIDENT & CEO, VOZ ADVISORS
Patient Engagement in Gene and Cell Therapeutic - What is different?
New York, New York, United States
photo
Grace Colon
CEO, INCARDA THERAPEUTICS
Digital Health in Respiratory Care – The Next Frontier
Newark, California, United States
photo
Christine Colvis
DIRECTOR, NCATS
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Bethesda, Maryland, United States
photo
David Coman
CEO, SCIENCE 37
Science 37
Playa Vista, California, United States
photo
Colleen Connolly
SENIOR COMMUNICATIONS MANAGER, GE HEALTHCARE LIFE SCIENCES
GE Healthcare Life Sciences - Soon to be Cytiva
Marlborough , Massachusetts, United States
photo
Timothy Cote, MD, MPH
CHIEF EXECUTIVE OFFICER, SILK ROAD THERAPEUTICS
Silk Road Therapeutics
Washington, District Of Columbia  , United States
photo
Athena Countouriotis, MD
PRESIDENT, CHIEF EXECUTIVE OFFICER, TURNING POINT THERAPEUTICS
Capital Markets Crystal Ball: Strategies for Equity Financing
Looking for the Next Targeted Oncology Blockbuster
San Diego, California, United States
photo
James Cummings
PRESIDENT, ICON - CLINICALRM
Applying technology to transform clinical trials for global outbreaks
Washington, United States
photo
Michael Curran
ASSOCIATE PROFESSOR, DEPARTMENT OF IMMUNOLOGY , MD ANDERSON CANCER CENTER
Future of IO Checkpoint Combinations
Houston, Texas, United States
photo
Bassil Dahiyat, Ph.D.
PRESIDENT AND CHIEF EXECUTIVE OFFICER, XENCOR
Bispecific Antibodies Catching Fire
Monrovia , California, United States
photo
Yu-Ming Dammann
ASSOCIATE GENERAL COUNSEL, GILEAD SCIENCES
CAR-T cell therapy: filing trends, opportunities and challenges to patentability
photo
Mark Dant
CHAIRMAN, EVERYLIFE FOUNDATION FOR RARE DISEASES
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
Dallas, Texas, United States
photo
Barry Datlof
CHIEF, BUSINESS DEVELOPMENT AND COMMERCIALIZATION, US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND, DEPARTMENT OF DEFENSE
Many Happy Returns – Federal Labs as Commercialization Partners Turning Public Support into Marketed Innovations
Fort Detrick, MD, Maryland, United States
photo
Mark Dertzbaugh, PhD
ACTING PRINCIPAL ASSISTANT FOR RESEARCH & TECHNOLOGY , U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
How to Leverage Military Non-Dilutive Funding for your Product Development Plan
Fort Detrick, Maryland, United States
photo
Lisa Deschamps
SVP & CHIEF BUSINESS OFFICER, AVEXIS, INC.
Triumphs and Challenges in the Journey to Commercializing a New Era of Medicine: Gene Therapy
photo
Ricardo Dolmetsch
GLOBAL HEAD OF NEUROSCIENCE, NOVARTIS
Digital biomarkers - a new dawn in CNS R&D
Cambridge, Massachusetts, United States
photo
John Dombrosky, MBA
CEO, OERTH BIO (BAYER AND ARVINAS JOINT VENTURE)
Targeted Protein Degradation: The New Kids on The Block
Durham, North Carolina, United States
photo
Oreola Donini, PhD
CHIEF SCIENTIFIC OFFICER, SOLIGENIX, INC.
Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance
Princeton, New Jersey, United States
photo
Megan Doyle
DIRECTOR, GLOBAL REGULATORY AND R&D POLICY, AMGEN
Companion Diagnostics: Could Co-Development be Expedited to Facilitate Access to Accelerated Novel Therapeutics?
Thousand Oaks, California, United States
photo
Mark Edwards
MANAGING DIRECTOR, BIOSCIENCE ADVISORS
Insights from the IPO Bioeconomy: What the data tells us
Walnut Creek, California, United States
photo
Alan Eisenberg
VICE PRESIDENT, GLOBAL GOVERNMENT RELATIONS & PUBLIC POLICY, ALNYLAM
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact without Congressional Authority?
Arlington, Virginia, United States
photo
Sebastian Engels
PARTNER, BOEHMERT & BOEHMERT LAW FIRM
Product Hopping, Evergreening, Patent Thickets – A story of Sharply Diverging Views
Berlin, Germany
photo
Steven Engle
CEO, COHBAR, INC.
Redefining What it Means to Get Old: New Breakthroughs in Aging Biology
Menlo Park, California, United States
photo
Onno Faber
CHAIRMAN AND FOUNDER, RDMD
Can artificial intelligence break the rare disease deadlock?
San Francisco, California, United States
photo
Denise Faustman
HEAD OF IMMUNOBIOLOGY LAB, MASSACHUSETTS GENERAL HOSPITAL
Future of IO Checkpoint Combinations
Charlestown, Massachusetts, United States
photo
Phil Febbo, MD
CMO, ILLUMINA
Fireside Chat with Dr. Phil Febbo, Chief Medical Officer, Illumina
photo
Howard Federoff, MD, PhD
CEO, ASPEN NEUROSCIENCE
Aspen Neuroscience
San Diego, California, United States
photo
Peter Fedichev, PhD
CEO, GERO
Gero
Singapore, Singapore
photo
Steve Ferguson
DEPUTY DIRECTOR, NATIONAL INSTITUTES OF HEALTH
Many Happy Returns – Federal Labs as Commercialization Partners Turning Public Support into Marketed Innovations
Rockville, Maryland, United States
photo
Stephanie Fertig
The Key Role of NIH in the Product Development Pipeline
photo
Michael Fine
MEDICAL DIRECTOR, HEALTHNET
Transforming the role of RWD: activating value through the lens of innovation
Huntington Beach, California, United States
photo
Michael Fitzhugh
NEWS EDITOR, BIOWORLD
'N of Few' - Clinical Trial Design for Small Cohorts
Berkeley, California, United States
photo
Scott Foraker, JD
PRESIDENT & CEO, A2 BIOTHERAPEUTICS
2020 Vision: Welcoming in a New Decade of Deal-making
Agoura Hills, California, United States
photo
Michael Frank
DIRECTOR, R&D STRATEGY, PFIZER
Pfizer & SparkBeyond
new york, New York, United States
photo
Tom Frohlich
CHIEF BUSINESS OFFICER, CHINOOK THERAPEUTICS
Precision Medicine Outside Oncology: One Size Does Not Fit All
Vancouver , British Columbia, Canada
photo
Steven Fruchtman
PRESIDENT & CEO, ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics, Inc.
Newtown, Pennsylvania, United States
photo
Nick Galli, JD
CHIEF BUSINESS OFFICER, CYTOMX
CytomX Therapeutics
South San Francisco, California, United States
photo
Steve Gardner
CEO, ROW ANALYTICS
Finding hidden treasure - how AI/ML can harness existing data to accelerate drug discovery
Kidlington, United Kingdom
photo
Ariel Garten
CO-FOUNDER & CHIEF EVANGELISM OFFICER, MUSEⓇ
MuseⓇ
Toronto, Ontario, Canada
photo
Albert Gianchetti
PRESIDENT AND CEO, XYLOCOR THERAPEUTICS, INC.
XyloCor Therapeutics, Inc.
MALVERN, Pennsylvania, United States
photo
John Gill
PART LEADER, SAMSUNG BIOLOGICS
Samsung BioLogics
Incheon, Korea - South Korea
photo
Brad Glasscock, PharmD
GROUP VICE PRESIDENT AND HEAD OF GLOBAL REGULATORY AFFAIRS, BIOMARIN
'N of Few' - Clinical Trial Design for Small Cohorts
photo
John Glasspool
CEO, ANTHOS THERAPEUTICS INC
Addressing the neglect in cardiovascular Disease development
Cambridge MA, Massachusetts, United States
photo
Zach Gobst
CEO, LEAPCURE
Leapcure
San Francisco, California, United States
photo
Mar Gonzales-Franco
RESEARCHER, MICROSOFT RESEARCH
The Immersive Medicine of the Future: At the convergence of smart sensors, virtual reality and artificial intelligence
Redmond, Washington, United States
photo
Eliseo Gonzalez
BIOTECH CONSULTANT, DROMEX INTERNACIONAL
Dromex Internacional
Buenos Aires, Argentina
photo
Phil Gotwals
GLOBAL HEAD, NIBR BD&L, NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH
Novartis
Cambridge, Massachusetts, United States
photo
Charley Grant, BA, CFA
COLUMNIST, WALL STREET JOURNAL
Looking for the Next Targeted Oncology Blockbuster
New York City, New York, United States
photo
Larry Green
CHIEF EXECUTIVE OFFICER, ABLEXIS & ALIVAMAB DISCOVERY SERVICES
Ablexis & AlivaMab Discovery Services
San Diego, California, United States
photo
Susan Gurley, JD
EXECUTIVE DIRECTOR, ANXIETY AND DEPRESSION ASSOCIATION OF AMERICA
Wild, Wild West of Cannabidiol (CBD): Is it Possible to Hold CBD to the Same Standards as Other Medicines to Protect Consumers, Patients, and Clinicians
Silver Spring, Maryland, United States
photo
Byoung Gwag
CEO, GNT PHARMA
GNT Pharma
Yonginsi, Gyeonggido, Korea - South Korea
photo
Todd Haim, PhD
CHIEF, OFFICE OF SMALL BUSINESS RESEARCH, NIH/NIA
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
Bethesda, Maryland, United States
photo
Marian Hajduch
ASSOCIATE PROFESSOR, IMTM
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Olomouc, Czech Republic
photo
Jeff Haley
DEVELOPMENT, CELANESE
Celanese
Florence, Kentucky, United States
photo
Kimball Hall
COO, ABZENA
Abzena
San Diego, California, United States
photo
Geraldine Hamilton
PRESIDENT AND CHIEF SCIENTIFIC OFFICER, EMULATE BIO
Applying technology to transform clinical trials for global outbreaks
Boston, Massachusetts, United States
photo
Dror Harats
CEO, VBL THERAPEUTICS
VBL Therapeutics
Modiin, Israel
photo
Christian Harding
CEO & CO-FOUNDER, VAXNEWMO
VaxNewMo
St. Louis, Missouri, United States
photo
David Harel
CO-FOUNDER AND CEO, CYTOREASON
CytoReason
Tel Aviv, Israel
photo
Robert Hariri, MD, PhD
CEO, CELULARITY
Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies
Warren, New Jersey, United States
photo
Christine Harrison
VICE PRESIDENT, PUBLIC AFFAIRS AND STAKEHOLDER ENGAGEMENT, ORCHARD THERAPEUTICS
Patient Engagement in Gene and Cell Therapeutic - What is different?
Boston, New York, United States
photo
Paul Hastings
PRESIDENT AND CEO, NKARTA THERAPEUTICS
Diversity and inclusion's biotech explosion: ERG and non-profit perspectives
San Francisco, California, United States
photo
Rachel Haurwitz, PhD
PRESIDENT AND CEO, CARIBOU BIOSCIENCES
True North: Maintaining your vision and letting scientific innovation be your guide
Berkeley, California, United States
photo
Daria Hazuda
VP, INFECTIOUS DISEASES DISCOVERY & CHIEF SCIENTIFIC OFFICER, MRL CAMBRIDGE EXPLORATORY CENTER, MERCK & CO
Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance
Cambridge, Massachusetts, United States
photo
Brenda Hefti, JD, PhD
SENIOR VICE PRESIDENT, INTELLECTUAL PROPERTY AND LICENSING, EXELIXIS
GETTING TO YES: Negotiating IP Terms in Contracts
Alameda, California, United States
photo
Abraham Heifets, PhD
CEO, CO-FOUNDER, ATOMWISE, INC.
Organs-on-a-Chip and AI Could Mean the End of Animal Testing in Drug Development
Atomwise, Inc.
San Francisco, California, United States
photo
Per Hellsund, MBA
CEO, CYBREXA THERAPEUTICS
Getting to the tumor: Beyond the first generation of tumor targeting technologies
New Haven, Connecticut, United States
photo
Rich Heyman, PhD
VICE CHAIRMAN OF THE BOARD OF TRUSTEES, SALK INSTITUTE FOR BIOLOGICAL STUDIES
Perspectives on Translational Research
photo
James Hickman, PhD
FOUNDER AND CHIEF SCIENTIST, HESPEROS INC.
Disruptive Thinking: New Tools To Transform Addiction Treatment
Orlando, Florida, United States
photo
Quita Highsmith, MBA
HEAD OF ALLIANCE & ADVOCACY RELATIONS IN GOVERNMENT AFFAIRS; CO-LEAD OF ADVANCING INCLUSIVE RESEARCH, GENENTECH
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
South San Francisco, California, United States
photo
Seiji Hirasaki
CEO, ORICIRO GENOMICS
OriCiro Genomics
Tokyo, Japan
photo
Steve Hitchcock, PhD
HEAD OF RESEARCH, TAKEDA
Perspectives on Translational Research
photo
Skye Hodson, PhD
DIRECTOR & ASSET STRATEGIST, SYNEOS HEALTH
Persuading Payers to Pay for Digital Therapeutics: How do you get coverage when doctors prescribe software? Real-outcomes data and DTx-related physician coding will help.
Farnborough, United Kingdom
Natalie Holles
Natalie Holles
PRESIDENT AND CHIEF EXECUTIVE OFFICER, AUDENTES, AN ASTELLAS COMPANY
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
photo
Sonke Holtorf, PhD
DIRECTOR HBC, EUROPEAN PATENT OFFICE
CAR-T cell therapy: filing trends, opportunities and challenges to patentability
Rijswijk (ZH), Netherlands
photo
Axel Hoos
SENIOR VICE PRESIDENT AND THERAPEUTIC AREA HEAD ONCOLOGY, GLAXO SMITH KLINE
Future of IO Checkpoint Combinations
Collegeville, Pennsylvania, United States
photo
Ken Horne
PRESIDENT & COO, TEON THERAPEUTICS, INC.
Teon Therapeutics, Inc.
Redwood City, California, United States
photo
Ahsan Huda
DIRECTOR, DATA SCIENCE, PFIZER
Can artificial intelligence break the rare disease deadlock?
photo
John Huemoeller
CHIEF EXECUTIVE OFFICER, AXIM BIOTECHNOLOGIES, INC.
AXIM Biotechnologies, Inc.
San Diego, California, United States
photo
Tom Hughes
CEO, NAVITOR PHARMACEUTICALS
Redefining What it Means to Get Old: New Breakthroughs in Aging Biology
Cambridge , Massachusetts, United States
photo
George Hunnewell
COO, RXMX
RxMx
Boston, Massachusetts, United States
photo
Stephen Hurst, JD
FOUNDER, DIRECTOR AND CEO, MIND MEDICINE
Disruptive Thinking: New Tools To Transform Addiction Treatment
Toronto, Ontario, Canada
photo
Albert Hwang, MD
MANAGING DIRECTOR, HEALTHCARE, INVESTMENT BAKING, MORGAN STANLEY
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
photo
Keith Ignotz
PRESIDENT & CEO, OCUMEDIC, INC.
OcuMedic,Inc.
Mullica Hill, New Jersey, United States
photo
Mridula Iyer
GENERAL MANAGER, PRECISION MEDICINE, QUEST DIAGNOSTICS
Developing a new diagnostic for a rare disease to fuel clinical trials and build a market
photo
Mandy Jackson
US WEST COAST EDITOR , SCRIP INTELLIGENCE
Derisking Early Research and Increasing Likelihood of Clinical Success
photo
Elizabeth Jalazo
UNC SCHOOL OF MEDICINE; DIRECTOR OF CLINICAL INTEGRATION, ANGELMAN SYNDROME FOUNDATION , UNC; ANGELMAN SYNDROME FOUNDATION
Wild, Wild West of Cannabidiol (CBD): Is it Possible to Hold CBD to the Same Standards as Other Medicines to Protect Consumers, Patients, and Clinicians
Chapel Hill, North Carolina, United States
photo
Derek Jantz, BA, PhD
CHIEF SCIENTIFIC OFFICER, PRECISION BIOSCIENCES
CARs in the Fast Lane? Universal Allogeneic Therapy Moving Forward
Durham, North Carolina, United States
photo
Elizabeth Jeffords
CHIEF COMMERCIAL & STRATEGY OFFICER, ALKAHEST
Battle of the Brains:Rethinking Neurodegenerative Disease Treatment
San Carlos, California, United States
photo
Sarah Jenna
CEO, MY INTELLIGENT MACHINES
My Intelligent Machines (MIMs)
Montreal, Quebec, Canada
photo
Jana Jensen, PhD
CHIEF OPERATING OFFICER, DEERFIELD MANAGEMENT | DEERFIELD DISCOVERY AND DEVELOPMENT COMPANY (3DC)
Derisking Early Research and Increasing Likelihood of Clinical Success
New York, New York, United States
photo
Allison Jeynes-Ellis
CEO, AVILLION LLP
Avillion LLP
London, United Kingdom
photo
Ramsey Johnson
FOUNDER AND CHAIRMAN, OUTBIO
Diversity and inclusion's biotech explosion: ERG and non-profit perspectives
Boston, Massachusetts, United States
photo
Sabrina Johnson
CEO, DARé BIOSCIENCE
Redefining BioPharma in a Female-Forward World
Daré Bioscience
san diego , California, United States
photo
Eric Johnston
CTO, SIGRID THERAPEUTICS
Sigrid Therapeutics AB
Stockholm, Sweden
photo
Patrick Jordan
CEO, MYCOVIA PHARMACEUTICALS, INC.
Redefining BioPharma in a Female-Forward World
Durham, North Carolina, United States
photo
Alan Joslyn, PhD
CEO, ORAGENICS, INC.
Oragenics, Inc.
Tampa, Florida, United States
photo
Doo Young Jung
CEO/FOUNDER, BIONETIX, INC.
Bionetix, Inc.
Suwon, Gyeonggi-do, Korea - South Korea
photo
Ashish Kachru, MBA, MS
CHIEF EXECUTIVE OFFICER, ALTRUISTA HEALTH
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Reston, Virginia, United States
photo
Rasika Kalamegham
GROUP DIRECTOR, US REGULATORY POLICY, GENENTECH
Digital Health: Innovation Meets Regulation
Patient-centricity 2.0: Are we ready for decentralized trials?
Washington, District Of Columbia  , United States
photo
SangWon Kang
CEO, VASTHERA CO. LTD.
VASTHERA Co. Ltd.
Seoul, Korea - South Korea
photo
Amit Kapoor
CHAIR, INSTITUTE FOR COMPETITIVENESS
The Lure of Universal Healthcare ! What India is doing in Healthcare
Gurgaon, Haryana, India
photo
Michael Keane, BS
DIRECTOR OF SEARCH AND EVALUATION AT GSK CONSUMER HEALTHCARE EXTERNAL INNOVATION, GSK CONSUMER HEALTHCARE
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Warren, New Jersey, United States
photo
Ellen Kelly
PROGRAM DIRECTOR, CORIELL INSTITUTE FOR MEDICAL RESEARCH
Coriell Institute for Medical Research
Camden, New Jersey, United States
photo
Annie Kennedy
CHIEF OF POLICY AND ADVOCACY, EVERYLIFE FOUNDATION
Advancing the Science of Patient Input: How Are We Doing?
Washington D.C., Virginia, United States
photo
David Kerwick
LEGAL DIRECTOR, MERCK
AI Innovations: To Patent or Not to Patent?
WHERE DID ALL THE HUMANS GO: Intellectual Property for AI
White Plains, New York, United States
photo
Kyu-Tae Kim
CSO, ABCLON
AbClon
Seoul, Korea - South Korea
photo
Thomas Kim
PRESIDENT & CEO, EPIVARIO INC.
PTSD treatment limitations and novel pharmacotherapy approaches to transform standard of care
Lansdale, Pennsylvania, United States
photo
Stephen Kingsmore
PRESIDENT AND CEO, RADY CHILDREN'S INSTITUTE FOR GENOMIC MEDICINE
Can artificial intelligence break the rare disease deadlock?
San Diego, California, United States
photo
Tobias Kloepper
CEO, AIGENPULSE
Finding hidden treasure - how AI/ML can harness existing data to accelerate drug discovery
Abingdon, United Kingdom
photo
Rob Knight
PROFESSOR OF PEDIATRICS, AFFILIATE PROFESSOR, COMPUTER SCI. & ENG., SCHOOL OF HEALTH SCI, UNIVERSITY OF CALIFORNIA SAN DIEGO
Next generation advances in human microbiome research
San Diego, California, United States
photo
Selina Koch, PhD
EXECUTIVE EDITOR, BIOCENTURY, INC.
Battle of the Brains:Rethinking Neurodegenerative Disease Treatment
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
photo
Michele Korfin
CHIEF OPERATING OFFICER, TYME TECHNOLOGIES, LLC
Tyme Technologies, LLC
New York, New York, United States
photo
Achim Krauss
CEO AND PRESIDENT, AXEROVISION, INC.
AxeroVision, Inc.
Carlsbad, California, United States
photo
Ryo Kubota
CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER, KUBOTA VISION INC.
Kubota Vision Inc.
Seattle, Washington, United States
photo
Hannah Kuchler
JOURNALIST, FINANCIAL TIMES
Redefining What it Means to Get Old: New Breakthroughs in Aging Biology
photo
Carl Kukkonen
PARTNER, JONES DAY
AI Innovations: To Patent or Not to Patent?
WHERE DID ALL THE HUMANS GO: Intellectual Property for AI
San Diego, California, United States
photo
Neil Kumar, Ph.D., PhD
CHIEF EXECUTIVE OFFICER, BRIDGEBIO
Capital Markets Crystal Ball: Strategies for Equity Financing
San Francisco, California, United States
photo
Jeff Kutok
CHIEF SCIENTIFIC OFFICER, INFINITY PHARMACEUTICALS
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
Cambridge, Massachusetts, United States
photo
Louise Lagerqvist
PARTNERING MANAGER, US, MEDINCELL
MedinCell
Jacou, France
photo
Arthur Lahr
CEO, KIADIA PHARMA
Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer
Amsterdam, Netherlands
photo
Lawrence Lamb Jr.
CHIEF SCIENTIFIC OFFICER, INCYSUS THERAPEUTICS
Incysus Therapeutics, Inc.
Birmingham, Alabama, United States
photo
Janet Lambert, MBA
CEO, ARM
Patient Engagement in Gene and Cell Therapeutic - What is different?
Washington DC, District Of Columbia, United States
photo
Matthew Lawrence
CHIEF EXECUTIVE OFFICER & CHIEF SCIENTIFIC OFFICER, VIRSCIO
Battle of the Brains:Rethinking Neurodegenerative Disease Treatment
photo
Bora Lee
IP & BD MANAGER, BIONOXX
Bionoxx Inc.
Yangsan-si, Korea - South Korea
photo
Kevin Lee, PhD
CEO, BICYCLE THERAPEUTICS
Getting to the tumor: Beyond the first generation of tumor targeting technologies
Lexington, Massachusetts, United States
photo
Kelvin Lee
INSTITUTE DIRECTOR, NIIMBL
Discover/Develop, but how will you Manufacturing your therapeutic?
Newark, Delaware, United States
Peter Lee
Peter Lee
CORPORATE VICE PRESIDENT, MICROSOFT HEALTHCARE, MICROSOFT
The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable
Seattle, Washington, United States
photo
Do Young Lee
CEO, OPTOLANE TECHNOLOGIES, INC.
OPTOLANE Technologies, Inc.
Seongnam-si, Korea - South Korea
photo
Chae J. Lee
CEO & PRESIDENT, YUNGJIN PHARM. CO., LTD.
Yungjin Pharm. Co., Ltd.
Seoul, Korea - South Korea
photo
Arlinda Lee, Ph.D.
ANALYST , CANACCORD GENUITY
Bispecific Antibodies Catching Fire
New York , New York, United States
photo
Christine Lemke, PhD
EVIDATION HEALTH, CO-FOUNDER AND PRESIDENT, EVIDATION HEALTH
The emerging role of digital biomarkers in cognitive impairment
San Mateo, California, United States
photo
Keith Leonard
CHAIRMAN AND CEO, UNITY BIOTECHNOLOGY
True North: Maintaining your vision and letting scientific innovation be your guide
Brisbane, California, United States
photo
Rachael Lester
VICE PRESIDENT OF CORPORATE DEVELOPMENT, HARPOON THERAPEUTICS
Insights from the IPO Bioeconomy: What the data tells us
photo
Pierre Leurent
CEO AND FOUNDER, VOLUNTIS
Persuading Payers to Pay for Digital Therapeutics: How do you get coverage when doctors prescribe software? Real-outcomes data and DTx-related physician coding will help.
Cambridge, Massachusetts, United States
photo
Kirsten Leute
PARTNER, UNIVERSITY RELATIONS, OSAGE UNIVERSITY PARTNERS
Derisking Early Research and Increasing Likelihood of Clinical Success
Bala Cynwyd, Pennsylvania, United States
photo
Monique Levy
CHIEF STRATEGY OFFICER, BLACKTHORN THERAPEUTICS
Precision Medicine Outside Oncology: One Size Does Not Fit All
San Francisco, California, United States
photo
John Lewis, PhD
CEO, NANOSTICS
Nanostics
Edmonton, Alberta, Canada
photo
Cynthia Li
DIRECTOR, BUSINESS DEVELOPMENT, EXELIXIS
GETTING IT 'JUST RIGHT': The Goldilock’s Strategy for Effective and Efficient IP Due Diligence Processes
Alameda, California, United States
photo
Jay Lichter, PhD
MANAGING DIRECTOR, AVALON VENTURES; PRESIDENT & CEO, COI PHARMACEUTICALS, AVALON VENTURES
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
La Jolla, California, United States
photo
Pedro Lichtinger
CHAIRMAN AND CEO, CHEMIOCARE
ChemioCare
New York, New York, United States
photo
Erick Lin
MEDICAL DIRECTOR, MEDICAL AFFAIRS LEAD, BLUE CROSS BLUE SHIELD ASSOCIATION
Access to personalized medicine drives utilization of genomic tests and targeted therapies
Temple City , California, United States
photo
George Lin
EVP & CFO, HUA MEDICINE
Hua Medicine
Hong Kong, Hong Kong
photo
Klaus Lindpaintner
CSO/CMO, INTERVENN
InterVenn
South San Francisco, California, United States
photo
Casey Lippmeier, PhD
VP OF R&D, CONAGEN
Conagen
Bedford, Massachusetts, United States
photo
Liz Lison
PRESIDENT, ADVOCEA
Companion Diagnostics: Could Co-Development be Expedited to Facilitate Access to Accelerated Novel Therapeutics?
San Francisco, California, United States
photo
Mallory Loflin, PhD
PRINCIPAL INVESTIGATOR & ASST PROFESSOR OF PSYCHIATRY, VETERANS AFFAIRS SAN DIEGO HEALTHCARE SYSTEM; UC SAN DIEGO SCHOOL OF MEDICINE
Wild, Wild West of Cannabidiol (CBD): Is it Possible to Hold CBD to the Same Standards as Other Medicines to Protect Consumers, Patients, and Clinicians
San Diego, California, United States
photo
Rob Long
EXECUTIVE DIRECTOR, UPLIFTING ATHLETES
Uplifting Athletes
Chester Springs, Pennsylvania, United States
photo
Ted Love, MD
CEO AND PRESIDENT, GLOBAL BLOOD THERAPEUTICS
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
San Francisco, California, United States
photo
James Lu
CO-FOUNDER AND SVP OF APPLIED GENOMICS, HELIX
Helix
San Mateo, California, United States
photo
Shun Luo
CEO, CHAIRMAN, JIANSHUN BIOSCIENCES
Thousand Oaks Biopharmaceuticals
Jianshun Biosciences
Shanghai, China
photo
Tia Lyles-Williams
FOUNDER & CEO, LUCASPYE BIO
LucasPye BIO, LLC
Elizabeth, New Jersey, United States
photo
Sandy Macrae
CEO, SANGAMO THERAPEUTICS
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
San Francisco, California, United States
photo
Shlomi Madar
VP HEALTHCARE SOLUTIONS, SIGNALS ANALYTICS
Signals Analytics
New York, New York, United States
photo
Nello Mainolfi, PhD
FOUNDER, PRESIDENT AND CSO, KYMERA
Targeted Protein Degradation: The New Kids on The Block
Cambridge, Massachusetts, United States
photo
Stanley Maloy, PhD
ASSOCIATE VICE PRESIDENT FOR INNOVATION, SAN DIEGO STATE UNIVERSITY
Diversity and Inclusion in the Bio-innovation Ecosystem
San Diego, California, United States
photo
Doug Manion, MD
CEO, KLEO PHARMACEUTICALS, INC.
Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies
Getting to the tumor: Beyond the first generation of tumor targeting technologies
New Haven, Connecticut, United States
photo
Elizabeth Mansfield
REGULATORY CONSULTANT, IVD REGULATORY STRATEGY
Companion Diagnostics: Could Co-Development be Expedited to Facilitate Access to Accelerated Novel Therapeutics?
Kensington, Maryland, United States
photo
Dominique Manu, PhD
EXAMINER, EUROPEAN PATENT OFFICE
CAR-T cell therapy: filing trends, opportunities and challenges to patentability
photo
Brad Margus
CHIEF EXECUTIVE OFFICER, CEREVANCE
Battle of the Brains:Rethinking Neurodegenerative Disease Treatment
Boston, Massachusetts, United States
Peter Marks
Peter Marks, MD, PhD
DIRECTOR, CENTERS FOR BIOLOGICS EVALUATION & RESEARCH, US FOOD & DRUG ADMINISTRATION
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Discover/Develop, but how will you Manufacturing your therapeutic?
Silver Spring, Maryland, United States
photo
Brian Martin, BS, MS
HEAD OF AI IN R&D INFORMATION RESEARCH, SENIOR PRINCIPAL DATA SCIENTIST, ABBVIE
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Lake Forest, Illinois, United States
photo
Linda Masat
V.P. BUSINESS DEVELOPMENT, TRIANNI INC.
Trianni, Inc
San Francisco, CA, California, United States
photo
Neal Masia, PhD
CEO, HEALTH CAPITAL GROUP
Financing transformative therapies: Specifying new and multi-party payment models
New York, New York, United States
photo
Osamu Matsuzaki
BOARD DIRECTOR, SENIOR EXECUTIVE OFFICER, HEAD OF R&D AND BD, ASAHI KASEI PHARMA CORPORATION
Asahi Kasei Pharma Corporation
Tokyo, Japan
photo
Allison Matusick
GLOBAL ACCOUNTS DIRECTOR, CORNING INCORPORATED
Corning Incorporated
Corning, New York, United States
photo
Greg Mayes
PRESIDENT AND CEO, ENGAGE THERAPEUTICS
Engage Therapeutics
Summit, New Jersey, United States
photo
James McArthur
FOUNDER & PRESIDENT, R&D, CYDAN
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Cambridge, Massachusetts, United States
photo
Andrew McCandlish
HEAD OF US BUSINESS DEVELOPMENT, PH PHARMA
Getting a seat at the table: how can new small companies enter the oncology space?
South San Francisco, California, United States
photo
Reenie McCarthy
CHIEF EXECUTIVE OFFICER, STEALTH BIOTHERAPEUTICS
Mitochondria – How the Relic from Biology Class Could be the Next Powerhouse for Biopharmaceutical Innovation
Newtown, Massachusetts, United States
photo
Barbara McClung
CHIEF LEGAL OFFICER AND CORPORATE SECRETARY, CARIBOU BIOSCIENCES
GETTING TO YES: Negotiating IP Terms in Contracts
GETTING IT 'JUST RIGHT': The Goldilock’s Strategy for Effective and Efficient IP Due Diligence Processes
Berkeley, California, United States
photo
Joshua McClure, MBA
CEO, MAXWELL BIOSCIENCES
MaxWell Biosciences
Austin , Texas, United States
photo
Mark McDonough
PRESIDENT, CEO & BOARD MEMBER , ONCOCELL MDX
How Can the Liquid Biopsy Market Realize Its $30B Potential?
Newport Beach, California, United States
photo
Matthew McMahon
FEDERAL PROGRAM STAFF, NIH SEED
The Key Role of NIH in the Product Development Pipeline
photo
Alice Mead, JD, LLM
VICE PRESIDENT, U.S. PUBLIC POLICY AND PUBLIC AFFAIRS , GREENWICH BIOSCIENCES
Wild, Wild West of Cannabidiol (CBD): Is it Possible to Hold CBD to the Same Standards as Other Medicines to Protect Consumers, Patients, and Clinicians
Carlsbad, California, United States
photo
Ravi Mehrota
SENIOR MANAGING DIRECTOR, BIOTECHNOLOGY EQUITY RESEARCH, EVERCORE ISI
Product Hopping, Evergreening, Patent Thickets – A story of Sharply Diverging Views
photo
Joseph (Joe) Melnik
PARTNER, JONES DAY
GETTING TO YES: Negotiating IP Terms in Contracts
Palo Alto, California, United States
photo
Pierre Meulien
EXECUTIVE DIRECTOR, INNOVATIVE MEDICINES INITIATIVE (IMI)
Can artificial intelligence break the rare disease deadlock?
Brussels, Belgium
photo
Philipp Mews
COFOUNDER , EPIVARIO INC.
PTSD treatment limitations and novel pharmacotherapy approaches to transform standard of care
New York, New York, United States
photo
Zhuqi Miao
INTERIM MANAGER, INSTITUTE OF PREDICTIVE MEDICINE , OKLAHOMA STATE UNIVERSITY—CENTER FOR HEALTH SYSTEMS INNOVATION (CHSI)
Oklahoma State University—Center for Health Systems Innovation (CHSI)
Stillwater, Oklahoma, United States
photo
Hiroshi Mikitani
CHAIRMAN AND CEO, RAKUTEN MEDICAL
Rakuten Medical
San Mateo, California, United States
photo
Michael Miller, PhD
CEO, PROTERIXBIO
Digital Health in Respiratory Care – The Next Frontier
Billerica, Massachusetts, United States
photo
Debra Miller
CHIEF EXECUTIVE OFFICER & FOUNDER, CUREDUCHENNE
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Newport Beach, California, United States
photo
Randal Mills
CHIEF EXECUTIVE OFFICER, NATIONAL MARROW DONOR PROGRAM (NMDP)/BE THE MATCH, BE THE MATCH
Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer
Oakland, CA , California, United States
photo
Frank Minella
FOUNDER & CEO, PAINQX
PainQx
Philadelphia, Pennsylvania, United States
photo
Vikalp Mohan
COO, CELONIC GROUP
CELONIC Group
Basel, Switzerland
photo
Gloria Montaron Estrada
GENERAL COUNSEL AND THE CHIEF INTELLECTUAL PROPERTY OFFICER OF BIOCERES GROUP , BIOCERES S.A.
Bioceres Crop Solutions Corp.
Rosario , Argentina
photo
Remo Moomiaie-Qajar
PRESIDENT AND CEO, CYTONUS THERAPEUTICS INC.
Cytonus Therapeutics
San Diego, California, United States
photo
Amanda Moore
CEO , ANGELMAN SYNDROME FOUNDATION
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
Indianapolis, Illinois, United States
photo
K. Scott Moorefield
CHIEF BUSINESS OFFICER, BOUNDLESS BIO INC.
Boundless Bio Inc.
La Jolla , California, United States
photo
Carolyn Mulroney
HEMATOLOGIST/MEDICAL ONCOLOGIST, ASSOCIATE PROFESSOR OF MEDICINE, UC SAN DIEGO HEALTH, UNIVERSITY OF CALIFORNIA SAN DIEGO
Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer
La Jolla, CA, California, United States
photo
Krishnan Nadabalan, BSc, PhD
PRESIDENT AND CHIEF EXECUTIVE OFFICER, INVENIAI
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Guilford, Connecticut, United States
photo
Siva Nadarajah
PRESIDENT AND CO-FOUNDER, JOGO HEALTH INC.
JOGO Health Inc.
Bridgewater, New Jersey, United States
photo
Sumathi Nambiar
DIRECTOR OF THE DIVISION OF ANTI-INFECTIVES, CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), FDA
Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance
Washington, United States
photo
Mahesh Narayanan
CEO, PEPVAX, INC.
PepVax, Inc.
Bethesda, Maryland, United States
photo
William Newell
CEO, SUTRO BIOPHARMA
2020 Vision: Welcoming in a New Decade of Deal-making
South San Francisco, California, United States
photo
Steven Nichtberger
CEO, PRESIDENT AND CHAIRMAN, CABALETTA BIO
Cabaletta Bio
Philadelphia, Pennsylvania, United States
photo
Alec Nielsen
CO-FOUNDER & CEO, ASIMOV
Asimov
Boston, Massachusetts, United States
photo
Brad Niles
COO, ARIZ PRECISION MEDICINE
ARIZ Precision Medicine
Davis, California, United States
photo
Marc Nivet, MBA
EXECUTIVE VICE PRESIDENT, INSTITUTIONAL ADVANCEMENT, UT SOUTHWESTERN MEDICAL CENTER
UT Southwestern Medical Center
Dallas, Texas, United States
photo
Gregg Nyberg
ASSOCIATE VICE PRESIDENT, BPD & CLINICAL MANUFACTURING, MERCK
Discover/Develop, but how will you Manufacturing your therapeutic?
Kenilworth, New Jersey, United States
photo
Kevin Outterson
EXECUTIVE DIRECTOR, CARB-X AND PROFESSOR OF LAW, BOSTON UNIVERSITY, CARB-X, BOSTON UNIVERSITY
How to fix the broken antibiotics market: a rare/orphan diseases case study
Boston, Massachusetts, United States
photo
Sanjay Padhi, PhD
DR, AMAZON WEB SERVICES, RESEARCH
The Immersive Medicine of the Future: At the convergence of smart sensors, virtual reality and artificial intelligence
California, United States
photo
Deborah Palestrant
PARTNER, HEAD OF 4:59, 5AM VENTURES
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
Waltham, Massachusetts, United States
photo
Lauren Palestrini, PhD
DIRECTOR OF RESEARCH, MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM
How to Leverage Military Non-Dilutive Funding for your Product Development Plan
Summerville, South Carolina, United States
photo
Valerie Paradiz, PhD
VICE PRESIDENT OF SERVICES AND SUPPORTS, AUTISM SPEAKS
Patient-centricity 2.0: Are we ready for decentralized trials?
photo
Yoon Jeong Park , PhD
CTO , NIBEC
NIBEC
SEOUL, Korea - South Korea
photo
Jerry Parrott
PRESIDENT AND CEO, BIOMARKER STRATEGIES, LLC
BioMarker Strategies, LLC
Rockville, Maryland, United States
photo
Richard Pascoe
CHAIRMAN AND CEO, HISTOGEN INC.
Histogen, Inc.
San Diego, California, United States
photo
Danielle Pasqualone, JD, PhD
VICE PRESIDENT, INTELLECTUAL PROPERTY, ALECTOR LLC
WHY PATENTS STILL MATTER: Developing a Global Patent Portfolio of Real Value as Your Company Grows
South San Francisco, California, United States
photo
Neel Patel
MANAGING DIRECTOR, PORTFOLIO & COMMERCIAL STRATEGY, SYNEOS HEALTH CONSULTING
Dealmaker’s Intentions: 2020 Market Outlook
photo
Snehal Patel
CEO, GREENWICH LIFESCIENCES
Greenwich LifeSciences
Sugar Land, Texas, United States
photo
Bray Patrick-Lake
DIRECTOR, STAKEHOLDER ENGAGEMENT, DUKE CLINICAL RESEARCH INSTITUTE
Addressing the neglect in cardiovascular Disease development
photo
Katie Payne
SVP, CORPORATE COMMUNICATIONS & EXTERNAL AFFAIRS, ORCHARD THERAPEUTICS
Orchard Therapeutics
Boston, Massachusetts, United States
photo
Cindy Perettie
CHIEF EXECUTIVE OFFICER , FOUNDATION MEDICINE
How Can the Liquid Biopsy Market Realize Its $30B Potential?
Cambridge, Massachusetts, United States
photo
Chad Pettit
EXECUTIVE DIRECTOR, GLOBAL VALUE, ACCESS AND POLICY, BIOSIMILARS, AMGEN
How can the U.S. cultivate a healthy and competitive biosimilars market?
Thousand Oaks, California, United States
photo
Ed Pezalla, MD, MPH
FOUNDER AND CEO, ENLIGHTENMENT BIOCONSULT, LLC
Persuading Payers to Pay for Digital Therapeutics: How do you get coverage when doctors prescribe software? Real-outcomes data and DTx-related physician coding will help.
Daytona Beach, Florida, United States
photo
Maria Pilar
HEAD OF UNIT - HEALTH INNOVATIONS, EUROPEAN COMMISSION
Does global real world evidence exist?
photo
Radu Pislariu
PRESIDENT & CEO, LAURENT PHARMACEUTICALS
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Montreal, Quebec, Canada
photo
Peter Pitts
PRESIDENT AND CO-FOUNDER, CENTER FOR MEDICINE IN THE PUBLIC INTEREST
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact without Congressional Authority?
New York, New York, United States
photo
Ivan Plavec
CBO, IMAGINAB
ImaginAb, Inc.
Inglewood, California, United States
photo
Jon Polak
CEO, MESENTECH INC
Mesentech
Vancouver, British Columbia, Canada
photo
Michael Postow
MEDICAL ONCOLOGIST, MEMORIAL SLOAN KETTERING CANCER CENTER
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
New York City, New York, United States
photo
Steven Powell
CEO, MONUMENT THERAPEUTICS
Digital biomarkers - a new dawn in CNS R&D
Cambridge, United Kingdom
photo
Michal Preminger
HEAD, JOHNSON & JOHNSON INNOVATION, EAST NORTH AMERICA, JOHNSON & JOHNSON INNOVATION
Derisking Early Research and Increasing Likelihood of Clinical Success
Cambridge, Massachusetts, United States
photo
Amy Price
CONSULTANT AND PATIENT ADVOCATE
Patient Engagement in Gene and Cell Therapeutic - What is different?
Omaha, Nebraska, United States
photo
Daryl Pritchard
SENIOR VICE PRESIDENT, SCIENCE POLICY, PERSONALIZED MEDICINE COALITION
Access to personalized medicine drives utilization of genomic tests and targeted therapies
Washington, District Of Columbia  , United States
photo
Pawel Przewiezlikowski
CEO, RYVU THERAPEUTICS
Ryvu Therapeutics
Krakow, Poland
photo
Cameron Pye, PhD
CEO, UNNATURAL PRODUCTS INC
Unnatural Products Inc.
Santa Cruz, California, United States
photo
Ammar Qadan
VICE PRESIDENT & GLOBAL HEAD OF MARKET ACCESS, ILLUMINA
Access to personalized medicine drives utilization of genomic tests and targeted therapies
San Diego, California, United States
photo
Kim Quaintance-Lunn
VP AND HEAD, REGULATORY POLICY, NORTH AMERICAN REGULATORY AFFAIRS, BAYER
How to fix the broken antibiotics market: a rare/orphan diseases case study
Washington, District Of Columbia  , United States
photo
Jill Quigley
CHIEF OPERATING OFFICER, PASSAGE BIO
Gene therapy: The long horizon and broad challenges
Philadelphia, Pennsylvania, United States
photo
Anthony Quinn
CHIEF EXECUTIVE OFFICER, AEGLEA BIOTHERAPEUTICS
Aeglea
Austin , Texas, United States
photo
Andrew Radin
CEO, TWOXAR
twoXAR
Mountain View, California, United States
photo
Lakshman Ramamurthy
SR. DIRECTOR, TEAM LEAD, GLOBAL REG, GLAXOSMITHKLINE INC.
Companion Diagnostics: Could Co-Development be Expedited to Facilitate Access to Accelerated Novel Therapeutics?
photo
Georges Rawadi
CEO, LNC THERAPEUTICS
Keys to the Cure: Will the Microbiome Live up to the Hype?
LNC Therapeutics
photo
BG Rhee
CEO, SCM LIFESCIENCE CO., LTD.
SCM Lifescience Co., Ltd.
Incheon, Korea - South Korea
photo
Rhonda Rhyne
PRESIDENT AND CEO, PREVENCIO, INC.
Prevencio, Inc.
Kirkland, Washington, United States
photo
William Rice, PhD
CEO, APTOSE BIOSCIENCES
Aptose Biosciences
San Diego, California, United States
photo
Tim Robertson
PRINCIPAL SCIENTIST, SCHRODINGER
Finding hidden treasure - how AI/ML can harness existing data to accelerate drug discovery
San Diego, California, United States
photo
Donna Robertson-Chow
SENIOR DIRECTOR INTELLECTUAL PROPERTY, DORF & NELSON LLP
AI Innovations: To Patent or Not to Patent?
Rye, New York, United States
photo
Chad Robins
CEO, ADAPTIVE BIOTECHNOLOGIES
The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable
photo
Angi Robinson
VICE PRESIDENT, CDS, AND RARE DISEASE AND PEDIATRICS, PREMIER RESEARCH
'N of Few' - Clinical Trial Design for Small Cohorts
photo
Lucas Rodriguez
CHIEF EXECUTIVE OFFICER , CERSCI THERAPEUTICS
CerSci Therapeutics
Dallas, Texas, United States
photo
Kent Rogers
SENIOR VICE PRESIDENT, CHIEF PHARMA CONTRACTING & PROCUREMENT OFFICER, OPTUMRX
Triumphs and Challenges in the Journey to Commercializing a New Era of Medicine: Gene Therapy
California,
photo
Dawn Rosarius
SENIOR EXECUTIVE SERVICE, PRINCIPAL ASSISTANT FOR ACQUISITION, U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
How to Leverage Military Non-Dilutive Funding for your Product Development Plan
Fort Detrick, Maryland, United States
photo
Donna Roscoe
MOLECULAR GENETICS BRANCH, CDRH, FDA
Companion Diagnostics: Could Co-Development be Expedited to Facilitate Access to Accelerated Novel Therapeutics?
Rockville, Maryland, United States
photo
Susan Rosenbaum
FOUNDER, CHAIRMAN & CHIEF EXECUTIVE OFFICER, LAUREN SCIENCES LLC
Lauren Sciences LLC
New York, New York, United States
photo
Jeff Ross
CEO, MIROMATRIX INC.
Miromatrix Inc.
Eden Prairie, Minnesota, United States
photo
Mark Rothera
PRESIDENT AND CEO, ORCHARD THERAPEUTICS
Gene therapy: The long horizon and broad challenges
London, United Kingdom
photo
Soumit Roy
VICE PRESIDENT, HEALTHCARE ANALYST. , JONES TRADING
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
New York City, New York, United States
photo
Christian Ruff
ASSOCIATE PHYSICIAN, DEPARTMENT OF CARDIOLOGY, BRIGHAM AND WOMEN’S HOSPITAL
Addressing the neglect in cardiovascular Disease development
photo
James Sabry, MD, PhD
GLOBAL HEAD, PHARMA PARTNERING, ROCHE
The Next Generation of Medicine - Cell Therapies, Gene therapies and Beyond
photo
Stephen Sammut
SENIOR FELLOW, HEALTH CARE MANAGEMENT AND LECTURER, ENTREPRENEURSHIP, WHARTON SCHOOL, WHARTON
The Lure of Universal Healthcare ! What India is doing in Healthcare
Philadelphia, Pennsylvania, United States
photo
Camille Samuels
PARTNER, VENROCK
True North: Maintaining your vision and letting scientific innovation be your guide
Palo Alto, California, United States
photo
Joel Sandler, PhD
ASSOCIATE PRINCIPAL, CELLO HEALTH BIOCONSULTING (PREVIOUSLY DEFINED HEALTH)
Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies
Brooklyn, New York, United States
photo
Peter Sandor, MD
SENIOR VICE PRESIDENT, ASTELLAS
Future of IO Checkpoint Combinations
Chicago, Illinois, United States
photo
Ioannis Sapountzis
CORP. SR. VICE PRESIDENT, BUS. DEVELOPMENT & LICENSING, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Boehringer Ingelheim
Ridgefield, Connecticut, United States
photo
Bo Saxberg MD PhD
PRESIDENT, DDO STRATEGIC SERVICES
Insights from the IPO Bioeconomy: What the data tells us
Scottsdale, Arizona, United States
photo
Emma Sceats
CHIEF EXECUTIVE OFFICER, ISOGENICA
Getting a seat at the table: how can new small companies enter the oncology space?
Little Chesterford, United Kingdom
photo
Gene Schaefer
SR. DIR LARGE MOLECULE API DEVELOPMENT AT JOHNSO, JANSSEN (J&J)
Discover/Develop, but how will you Manufacturing your therapeutic?
Horsham, Pennsylvania, United States
photo
Mark Scheideler, PhD
FOUNDER, HUMANFIRST THERAPEUTICS LLC
Charcot-Marie-Tooth Association
Silver Spring, Maryland, United States
photo
Michael Schrader
CEO, VAXESS TECHNOLOGIES
Vaxess Technologies
Cambridge, Massachusetts, United States
photo
Stefanie Schubert
PROFESSOR OF ECONOMICS, HEIDELBERG UNIVERSITY
Striking the delicate balance of externalizing biopharma R&D to maximize innovation: Strategies to buy vs. build
Heidelberg, Quebec, Germany
photo
Thomas Schuetz, M.D., Ph.D.
CO-FOUNDER AND CHIEF EXECUTIVE OFFICER, COMPASS THERAPEUTICS
Bispecific Antibodies Catching Fire
Cambridge, Massachusetts, United States
photo
Lukas Schüpbach
CEO, BACTHERA AG
Keys to the Cure: Will the Microbiome Live up to the Hype?
photo
Fabien Sebille
DIRECTOR, BUSINESS DEVELOPMENT & COMMERCIAL INSIGHTS, DEBIOPHARM INTERNATIONAL SA
Debiopharm International SA
Lausanne, Switzerland
photo
Lynn Seely
PRESIDENT AND CHIEF EXECUTIVE OFFICER, MYOVANT SCIENCES
Redefining BioPharma in a Female-Forward World
San Francisco, California, United States
photo
Prad Sekar
CHIEF EXECUTIVE OFFICER, CB2 INSIGHTS
CB2 Insights
Mississauga, Ontario, Canada
photo
Bryan Selby
VICE PRESIDENT, RETROPHIN
Retrophin
San Diego, California, United States
photo
Jeff Settleman, PhD
CHIEF SCIENTIFIC OFFICER FOR ONCOLOGY RESEARCH AND DEVELOPMENT, PFIZER
Fireside Chat with Dr. Jeff Settleman, Chief Scientific Officer for Oncology Research and Development, Pfizer
photo
Khushboo Sharma, MBA, RAC
DEPUTY DIRECTOR OF OPERATIONS, OFFICE OF NEW DRUGS, CENTER FOR DRUG EVALUATION AND RESEARCH, U.S. FOOD AND DRUG ADMINISTRATION (FDA)
Does the U.S. FDA’s New Drugs Regulatory Program Modernization Impact your Drug Development Program?
photo
Agam Sheth
DIRECTOR, BUSINESS DEVELOPMENT AND LICENSING, MERCK RESEARCH LABORATORIES, MERCK & CO., INC
Next generation advances in human microbiome research
West Point, Pennsylvania, United States
photo
Richard Sheurmann
DIRECTOR, J CRAIG VENTER INSTITUTE
Finding hidden treasure - how AI/ML can harness existing data to accelerate drug discovery
La Jolla, California, United States
photo
Cailin Sibley, MD
MEDICAL ADVISOR, ELI LILLY
Precision Medicine Outside Oncology: One Size Does Not Fit All
San Diego, California, United States
photo
Greg Silberman
VICE PRESIDENT AND DEPUTY GENERAL COUNSEL , BLACKBERRY CORPORATION
WHERE DID ALL THE HUMANS GO: Intellectual Property for AI
Mountain View, California, United States
photo
Courtney Silverthorn, PhD, MS
DEPUTY DIRECTOR, TECHNOLOGY PARTNERSHIPS OFFICE, NIST
Many Happy Returns – Federal Labs as Commercialization Partners Turning Public Support into Marketed Innovations
Gaithersburg, Maryland, United States
photo
Kevin Sin
SVP, WORLDWIDE BUSINESS DEVELOPMENT, GLAXOSMITHKLINE
GlaxoSmithKline
San Francisco, California, United States
photo
Kristen Slaoui
VICE PRESIDENT OF BUSINESS DEVELOPMENT, PHARMACEUTICALS COMMERCIAL PORTFOLIO AT GSK, GSK
Striking the delicate balance of externalizing biopharma R&D to maximize innovation: Strategies to buy vs. build
Collegeville, Pennsylvania, United States
photo
Yochi Slonim
CO-FOUNDER & CEO, ANIMA BIOTECH INC
Anima Biotech Inc
Bernardsville, New Jersey, United States
photo
Bob Smith
SENIOR VICE PRESIDENT, GLOBAL GENE THERAPY BUSINESS, RARE DISEASE, GLOBAL INNOVATION PHARMA, PFIZER, INC.
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
photo
Tamas Sohajda
R&D DIRECTOR, CYCLOLAB LTD.
Cyclolab Ltd.
Budapest, Hungary
photo
Cornell Stamoran
VP, CATALENT
Patient Perspectives on Design and Usability of Biotherapeutics
Somerset, New Jersey, United States
photo
Otello Stampacchia, Ph.D.
MANAGING DIRECTOR, OMEGA FUNDS
Capital Markets Crystal Ball: Strategies for Equity Financing
Boston, Massachusetts, United States
photo
Peter Stein
DIRECTOR, OFFICE OF NEW DRUGS, CENTER FOR DRUG EVALUATION AND RESEARCH, U.S. FOOD AND DRUG ADMINISTRATION (FDA)
Does the U.S. FDA’s New Drugs Regulatory Program Modernization Impact your Drug Development Program?
photo
Lance Stewart, PhD, MBA
CHIEF STRATEGY AND OPERATIONS OFFICER , INSTITUTE FOR PROTEIN DESIGN AT UNIVERSITY OF WASHINGTON
New Frontiers in Computational Protein Design
Seattle, Washington, United States
photo
David Stover, BS, PhD
CSO, QWIXEL THERAEPUTICS, LLC
Qwixel Therapeutics LLC
Los Angeles, California, United States
photo
Peter Strumph
CEO, AMYGDALA NEUROSCIENCES
Amygdala Neurosciences, Inc.
San Francisco, California, United States
photo
Melissa Stundick, PhD
EXECUTIVE DIRECTOR OF STRATEGIC ALLIANCES, SPERO THERAPEUTICS
Licensing Clinical-Stage Assets to Greater China
Cambridge, Massachusetts, United States
photo
Mark Summers
EXECUTIVE DIRECTOR, TECHNOLOGY AND INNOVATION, EMISSIONS REDUCTION ALBERTA (ERA)
Emissions Reduction Alberta
Edmonton, Alberta, Canada
photo
Alex Szidon
VICE PRESIDENT AND HEAD OF BUSINESS DEVELOPMENT, GRED AT GENENTECH, A MEMBER OF THE ROCHE GROUP, GENENTECH
Perspectives on Translational Research
photo
Philip Tagari, PhD
VICE PRESIDENT, THERAPEUTIC DISCOVERY, AMGEN
New Frontiers in Computational Protein Design
Thousand Oaks, California, United States
photo
Paul Peter Tak, PhD
PRESIDENT & CEO, KINTAI THERAPEUTICS
Kintai Therapeutics
Cambridge, Massachusetts, United States
photo
Amir Tamiz
DIRECTOR, DIVISION OF TRANSLATIONAL RESEARCH, NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Transforming Pain Research from Academia to Industry
Bethesda, Maryland, United States
photo
Jason Tardio
CHIEF COMMERCIAL OFFICER, OVID THERAPEUTICS
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
photo
Jami Taylor
PARTNER, HEAD OF BUSINESS DEVELOPMENT, RUEONE INVESTMENTS
How to fix the broken antibiotics market: a rare/orphan diseases case study
Boston, Massachusetts, United States
photo
Ted Tentoff
MANAGING DIRECTOR AND SENIOR RESEARCH ANALYST, PIPER JAFFRAY
Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer
New York , New York, United States
photo
David Thomas, CFA
VICE PRESIDENT, INDUSTRY RESEARCH, BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
What's Next: The Landscape of Innovation in 2020 and Beyond
photo
Peter Thompson
CO-FOUNDER, PRESIDENT, CHIEF EXECUTIVE OFFICER, AND CHAIRMAN, SILVERBACK THERAPEUTICS
Getting to the tumor: Beyond the first generation of tumor targeting technologies
Seattle , Washington, United States
photo
Peter Thompson, MD
CO-FOUNDER, PRESIDENT, CHIEF EXECUTIVE OFFICER, AND CHAIRMAN, SILVERBACK THERAPEUTICS
True North: Maintaining your vision and letting scientific innovation be your guide
Seattle, Washington, United States
photo
Sandra Thurman
DIRECTOR, JOSEPH W. BLOUNT CENTER FOR HEALTH AND HUMAN RIGHTS, EMORY UNIVERSITY
The Next Frontier in HIV Innovation: the Transition to No Transmission
Atlanta, Georgia, United States
photo
Wenzhi Tian
FOUNDER, CHAIRMAN & CEO, IMMUNEONCO BIOPHARMA
ImmuneOnco Biopharma
Shanghai, China
photo
Chris Tieken
BUSINESS DEVELOPMENT MANAGER, EATRIS
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Amsterdam, Netherlands
photo
Karen Tkach Tuzman, PhD
ASSOCIATE EDITOR, BIOCENTURY
New Frontiers in Computational Protein Design
San Francisco, California, United States
photo
Jeff Tong, PhD
PARTNER, THIRD ROCK VENTURES
Targeted Protein Degradation: The New Kids on The Block
San Francisco, California, United States
photo
Helen Torley, MB, MRCP
CEO, HALOZYME
Diversity and inclusion's biotech explosion: ERG and non-profit perspectives
San Diego, California, United States
photo
Sofia Touami
SR. DIRECTOR, BUSINESS DEVELOPMENT & ALLIANCE MANAGEMENT , NGM BIOPHARMACEUTICALS
GETTING IT 'JUST RIGHT': The Goldilock’s Strategy for Effective and Efficient IP Due Diligence Processes
South San Francisco, California, United States
photo
Alessio Travaglia, PhD
SCIENTIFIC PROGRAM OFFICER, ALZHEIMER’S DISEASE DISCOVERY FOUNDATION (ADDF)
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
New York, New York, United States
photo
Matt Tremblay
CHIEF OPERATING OFFICER, THE SCRIPPS RESEARCH INSTITUTE AND CALIBR (A DIVISION OF SCRIPPS RESEARCH)
Perspectives on Translational Research
photo
Chelsea Trengrove
PROGRAM MANAGER, EMPATICA
Empatica
Boston, Massachusetts, United States
photo
Andrew Trister, MD, MSE, PhD
DEPUTY DIRECTOR, INNOVATION TECHNOLOGY SOLUTIONS, GATES FOUNDATION
The emerging role of digital biomarkers in cognitive impairment
Seattle, Washington, United States
photo
Cameron Turtle, PhD
CHIEF BUSINESS OFFICER, EIDOS THERAPEUTICS
Precision Medicine Outside Oncology: One Size Does Not Fit All
photo
Michael Twomey
SHAREHOLDER, WOLF GREENFIELD
CARs in the Fast Lane? Universal Allogeneic Therapy Moving Forward
Boston, Massachusetts, United States
photo
Sam Ulin, MS
MANAGING DIRECTOR, CLEARVIEW HEALTHCARE PARTNERS
What's Next: The Landscape of Innovation in 2020 and Beyond
photo
Lisa Urquhart
EDITOR, VANTAGE, EVALUATE LTD.
Is it time to reconsider M&A’s role in portfolio building?
London, United Kingdom
photo
Pujita Vaidya, MPH
DIRECTOR, GLOBAL REGULATORY AND R&D POLICY, AMGEN
Innovative and Efficient Trial Designs and Statistical Approaches in Small Patient Populations: Rare Diseases and Pediatrics
Advancing the Science of Patient Input: How Are We Doing?
Washington D.C., United States
photo
Jennifer Van Eyk
CO-DIRECTOR PRECISION HEALTH, CEDARS-SINAI PRECISION BIOMARKER LABORATORIES
Cedars-Sinai Health System
Los Angeles, California, United States
photo
Chris Varma, PhD
PRESIDENT AND CEO, FRONTIER MEDICINES
Targeted Protein Degradation: The New Kids on The Block
South San Francisco, California, United States
photo
Dhivya Venkat
CHIEF EXECUTIVE OFFICER & CO-FOUNDER, ESYA LABS
Battle of the Brains:Rethinking Neurodegenerative Disease Treatment
photo
Kenneth Verburg
SENIOR VICE PRESIDENT, PFIZER
Transforming Pain Research from Academia to Industry
Morrisville, North Carolina, United States
photo
Bruno Villetelle, MENG, MSc
HEAD OF DATA AND DIGITAL, GLOBAL DRUG DEVELOPMENT , NOVARTIS
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Basel, Switzerland
photo
Vlad Vitoc
CEO, MAIA BIOTECHNOLOGY, INC
MAIA Biotechnology, Inc
Chicago, Illinois, United States
photo
Tuan vo-Dinh
PROFESSOR AND DIRECTOR, DUKE UNIVERSITY
The Immersive Medicine of the Future: At the convergence of smart sensors, virtual reality and artificial intelligence
Durham, North Carolina, United States
photo
Christopher Walsh
VICE-PRESIDENT, LEGAL, DENALI THERAPEUTICS
WHY PATENTS STILL MATTER: Developing a Global Patent Portfolio of Real Value as Your Company Grows
South San Francisco, California, United States
photo
Jassy Wang
CEO, MEGAPRO BIOMEDICAL CO. LTD.
MegaPro Biomedical Co., Ltd.
Hsinchu, Taiwan
photo
Yan Wang
PRESIDENT/CSO, GNOMEGEN
Gnomegen
San Diego, California, United States
photo
Jim Bob Ward
CEO, DATATRAK, INTERNATIONAL, INC.
Datatrak, International, Inc.
Mayfield Heights, Ohio, United States
photo
Richard Ward, PhD
DIRECTOR, ONCOLOGY SEARCH AND EVALUATION, ASTRAZENECA
Many Happy Returns – Federal Labs as Commercialization Partners Turning Public Support into Marketed Innovations
Cambridge, United Kingdom
photo
Keith Ward
PRESIDENT & CHIEF EXECUTIVE OFFICER, INTERVEXION THERAPEUTICS
InterveXion Therapeutics
Little Rock, Arkansas, United States
photo
Mitchell Warren
EXECUTIVE DIRECTOR, AVAC
The Next Frontier in HIV Innovation: the Transition to No Transmission
New York, New York, United States
photo
Tamera Weisser, BS, JD, PhD
PARTNER, JONES DAY
Insights from the IPO Bioeconomy: What the data tells us
San Diego, California, United States
photo
Danny Wells
SR. DATA SCIENTIST, PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
Immunai
San Francisco, California, United States
photo
James West III
CEO, CLARA BIOTECH, INC.
Clara Biotech, Inc.
Lawrence, Kansas, United States
photo
John Westman
EXECUTIVE VICE PRESIDENT AND CO-FOUNDER, NOVELLUS, INC.
Novellus, Inc.
Cambridge, Massachusetts, United States
photo
John Whyte
CHIEF MEDICAL OFFICER, WEBMD
Redefining BioPharma in a Female-Forward World
New York, New York, United States
photo
Terry Wilcox
EXECUTIVE DIRECTOR, PATIENTS RISING
Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage
Reston, Virginia, United States
photo
Troy Wilson, JD, PhD
PRESIDENT AND CHIEF EXECUTIVE OFFICER, KURA ONCOLOGY
Looking for the Next Targeted Oncology Blockbuster
San Diego, California, United States
photo
Chad Womack, PhD
THE ERNEST E. JUST FELLOWSHIP PROGRAM, UNITED NEGRO COLLEGE FUND , UNITED NEGRO COLLEGE FUND
Diversity and Inclusion in the Bio-innovation Ecosystem
Washington D.C., District Of Columbia  , United States
photo
Wayne Woodard
CEO, ARGONAUT MANUFACTURING SERVICES
Argonaut Manufacturing Services
Carlsbad, California, United States
photo
Jonathan Wosen
SCIENCE JOURNALIST
The Next Frontier in HIV Innovation: the Transition to No Transmission
photo
Tong Xu
CHIEF REPRESENTATIVE, CTTQ
Chia Tai Tianqing Pharmaceutical Group Co. Ltd.
San Diego, California, United States
photo
Mylene Yao
CEO AND COFOUNDER, UNIVFY
Univfy
Los Altos, California, United States
photo
Ping Yeh, MBA
CO-FOUNDER AND CEO, STEMONIX
Organs-on-a-Chip and AI Could Mean the End of Animal Testing in Drug Development
Maple Grove, Minnesota, United States
photo
Stephanie Yonker
VICE PRESIDENT OF LEGAL AND CORPORATE SECRETARY, ALECTOR
GETTING IT 'JUST RIGHT': The Goldilock’s Strategy for Effective and Efficient IP Due Diligence Processes
South San Francisco, California, United States
photo
Jin-San Yoo
CEO, PHARMABCINE
PharmAbcine
Daejeon,, Korea - South Korea
photo
John Young
CHIEF BUSINESS OFFICER, PFIZER, INC.
Precision Dealmaking
photo
Sikder Zakir, MBBS
CEO, HISTOFI, INC.
Histofi, Inc.
Manhattan Beach, California, United States
photo
Frederic Zenhausern
PROFESSOR AND DIRECTOR, UNIVERSITY OF ARIZONA
The Immersive Medicine of the Future: At the convergence of smart sensors, virtual reality and artificial intelligence
Phoenix, Arizona, United States
photo
Keely Zipp
VP, CORPORATE DEVELOPMENT AND COMMERCIAL STRATEGY, CYBREXA THERAPEUTICS
Getting to the tumor: Beyond the first generation of tumor targeting technologies
New Haven, Connecticut, United States
Load More